Regulatory Sourcebook eBook
Read the article:
Changing the Course of Drug Shortages
Read the eBook:
Pharmaceutical Technology's Regulatory Sourcebook eBook
News|Articles|September 16, 2021
- Pharmaceutical Technology, Regulatory Sourcebook, September 2021
- Volume 2021 eBook
- Issue 3
Changing the Course of Drug Shortages
Author(s)Meg Rivers
The COVID-19 pandemic has further impacted ongoing drug shortage issues; essential action is needed to avoid repeating previous mistakes.
Advertisement
Drug shortages were a major concern before the COVID-19 pandemic, which only served to further add pressure to an imperfect supply chain. The COVID-19 pandemic placed added pressure on bio/pharma’s imperfect supply chain, contributing to ongoing drug shortages and creating some new challenges. What has the industry learned from the pandemic and will practices and supply-related decisions change going forward?
Regulatory Sourcebook
About the author
Meg Rivers is a senior editor at Pharmaceutical Technology, Pharmaceutical Technology Europe, and BioPharm International.
Article Details
Pharmaceutical Technology
eBook: Regulatory Sourcebook, September 2021
September 2021
Pages: 16-22
Citation
When referring to this article, please cite it as M. Rivers, “Changing the Course of Drug Shortages," Pharmaceutical Technology Regulatory Sourcebook eBook (September 2021).
Articles in this issue
about 4 years ago
Understanding Combination Product Regulationsabout 4 years ago
Considering Titanium Dioxide Regulatory Changesabout 4 years ago
The Real Danger of Substandard and Counterfeit COVID-19 Vaccinesabout 4 years ago
Industry Organizations Assist Pharma During the Pandemic and Beyondabout 4 years ago
Mapping Out Pharma’s Regulatory Future in EuropeNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
